CODA Genomics
Latest round
- Series C
Last raised
- Jul 2007
Total raised
- $9.2M
Investors
- 5
About CODA Genomics
CODA Genomics specializes in gene synthesis, providing products that enable researchers to construct and express synthetic genes. Founded in Laguna Hills, US, the company has remained focused on developing innovative solutions in the biotechnology sector.CODA Genomics specializes in gene synthesis solutions, primarily through its flagship offerings: CODA Gene Kits and CODExpress Gene Kits. These products enable researchers to assemble custom synthetic genes and express proteins with optimized constructs efficiently. CODA Gene Kits utilize advanced oligonucleotide assembly methods to ensure high-quality gene synthesis tailored to specific research needs, while CODExpress Gene Kits focus on accelerating custom protein expression, facilitating robust gene assembly, and achieving high protein yields. The company's solutions cater to a diverse clientele, including academic institutions, biotechnology firms, and pharmaceutical companies, by addressing challenges in synthetic biology and protein production.CODA Genomics operates primarily through a B2B model, providing its gene synthesis products to research institutions and commercial entities within the biotechnology and pharmaceutical sectors. The company’s revenue structure includes direct sales of CODA Gene Kits and CODExpress Gene Kits, which are packaged with pre-mixed oligonucleotides and reagents required for quick assembly. Customers typically engage in one-time purchases or repeat orders based on their ongoing research needs. Each product is designed to meet specific requirements, contributing to a reliable revenue stream based on the consistent demand for innovative synthetic biology solutions. The company aims to introduce new gene synthesis products designed to meet emerging research needs over the next 18 months. Additionally, CODA Genomics is looking to enter new markets in Asia and Europe by the end of 2008, focusing on increasing its footprint in regions with growing biotechnology sectors.
Who invested in CODA Genomics
5 investors across 3 rounds
See all investors in CODA Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CODA Genomics
Who invested in CODA Genomics?
CODA Genomics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CODA Genomics raised?
CODA Genomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CODA Genomics last raise money?
CODA Genomics's most recent round on record is a Series C, in Jul 2007.
What does CODA Genomics do?
CODA Genomics specializes in gene synthesis, providing products that enable researchers to construct and express synthetic genes.
Where is CODA Genomics headquartered?
CODA Genomics is headquartered in Laguna Hills, US.
Which VCs invest in companies like CODA Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CODA Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like CODA Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.